Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate - Abstract

PURPOSE: The purpose of the study is to determine short-term reproducibility of apparent diffusion coefficient (ADC) estimated from diffusion-weighted magnetic resonance (DW-MR) imaging of the prostate.

METHODS: Fourteen patients with biopsy-proven prostate cancer were studied under an Institutional Review Board-approved protocol. Each patient underwent two, consecutive and identical DW-MR scans on a 3T system. ADC values were calculated from each scan and a deformable registration was performed to align corresponding images. The prostate and cancerous regions of interest (ROIs) were independently analyzed by two radiologists. The prostate volume was analyzed by sextant. Per-voxel absolute and relative percentage variations in ADC were compared between sextants. Per-voxel and per-ROI variations in ADC were calculated for cancerous ROIs.

RESULTS: Per-voxel absolute difference in ADC in the prostate ranged from 0 to 1.60 × 10-3 mm2/s (per-voxel relative difference 0% to 200%, mean 10.5%). Variation in ADC was largest in the posterior apex (0% to 200%, mean 11.6%). Difference in ADC variation between sextants was not statistically significant. Cancer ROIs' per-voxel variation in ADC ranged from 0.001 × 10-3 to 0.841 × 10-3 mm2/s (0% to 67.4%, mean 11.2%) and per-ROI variation ranged from 0 to 0.463 × 10-3 mm2/s (mean 0.122 × 10-3 mm2/s).

CONCLUSIONS: Variation in ADC within the human prostate is reasonably small, and is on the order of 10%.

Written by:
Sadinski M, Medved M, Karademir I, Wang S, Peng Y, Jiang Y, Sammet S, Karczmar G, Oto A.   Are you the author?
Department of Radiology, University of Chicago, 5841 S. Maryland Avenue, MC 2026, Chicago, IL, 60637, USA.  

Reference: Abdom Imaging. 2015 Mar 25. Epub ahead of print.
doi: 10.1007/s00261-015-0396-x


PubMed Abstract
PMID: 25805558

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe